Toxicidad por salicilatos

1. Hanzlik PJ. A study of the toxicity of the salicylates based on clinical statistics. JAMA 1913;60:957-62 (https://jamanetwork .com/journals/jama/article-abstract/214639).

2. Starko KM. Salicylates and pandemic influenza mortality, 1918-1919 pharmacology, pathology, and historic evidence. Clin Infect Dis 2009;49:1405-10.

3. Montinari MR, Minelli S, De Caterina R. The first 3500 years of aspirin history from its roots — a concise summary. Vascul Pharmacol 2019;113:1-8.

4. Chyka PA, Erdman AR, Christianson G, et al. Salicylate poisoning: an evidencebased consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2007;45:95-131.

5. Levy G. Clinical pharmacokinetics of aspirin. Pediatrics 1978;62:Suppl:867-72.

6. Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 1985;10:164-77.

7. Yü TF, Gutman AB. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest 1959;38:1298-315.

8. Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd annual report. Clin Toxicol (Phila) 2015;53:962-1147.

9. Gummin DD, Mowry JB, Spyker DA, et al. 2018 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th annual report. Clin Toxicol (Phila) 2019;57:1220-413.

10. Anderson RJ, Potts DE, Gabow PA, Rumack BH, Schrier RW. Unrecognized adult salicylate intoxication. Ann Intern Med 1976;85:745-8.

11. Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J 2002;19:206-9.

12. Yip L, Dart RC, Gabow PA. Concepts and controversies in salicylate toxicity. Emerg Med Clin North Am 1994;12:351-64.

13. Moss MJ, Fisher JA, Kenny TA, et al. Salicylate toxicity after undetectable serum salicylate concentration: a retrospective cohort study. Clin Toxicol (Phila) 2019; 57:137-40.

14. Wortzman DJ, Grunfeld A. Delayed absorption following enteric-coated aspirin overdose. Ann Emerg Med 1987;16: 434-6.

15. Rivera W, Kleinschmidt KC, Velez LI, Shepherd G, Keyes DC. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion. Ann Pharmacother 2004;38:1186-8.

16. Levy G. Pharmacokinetics of salicylate elimination in man. J Pharm Sci 1965; 54:959-67.

17. Glassock RJ, Bleyer AJ, Hricik DE, Palmer BF. The 2010 Nephrology Quiz and Questionnaire: part 1. Clin J Am Soc Nephrol 2011;6:2318-27.

18. Thompson TM, Toerne T, Erickson TB. Salicylate toxicity from genital exposure to a methylsalicylate-containing rubefacient. West J Emerg Med 2016;17:181-3.

19. Swain AR, Dutton SP, Truswell AS. Salicylates in foods. J Am Diet Assoc 1985; 85:950-60.

20. Duthie GG, Wood AD. Natural salicylates: foods, functions and disease prevention. Food Funct 2011;2:515-20.

21. Greer HD III, Ward HP, Corbin KB. Chronic salicylate intoxication in adults. JAMA 1965;193:555-8.

22. Steele TE, Morton WA Jr. Salicylateinduced delirium. Psychosomatics 1986; 27:455-6.

23. Paul BN. Salicylate poisoning in the elderly: diagnostic pitfalls. J Am Geriatr Soc 1972;20:387-90.

24. Anderson RJ. Asterixis as a manifestation of salicylate toxicity. Ann Intern Med 1981;95:188-9.

25. Crichton JU, Elliott GB. Salicylate as a dangerous drug in infancy and childhood: a survey of 58 cases of salicylate poisoning. Can Med Assoc J 1960;83:1144-7.

26. Bailey RB, Jones SR. Chronic salicylate intoxication: a common cause of morbidity in the elderly. J Am Geriatr Soc 1989;37:556-61.

27. Pei YP, Thompson DA. Severe salicylate intoxication mimicking septic shock. Am J Med 1987;82:381-2.

28. Leatherman JW, Schmitz PG. Fever, hyperdynamic shock, and multiple-system organ failure: a pseudo-sepsis syndrome associated with chronic salicylate intoxication. Chest 1991;100:1391-6.

29. Smith MJ, Dawkins PD. Salicylate and enzymes. J Pharm Pharmacol 1971;23: 729-44.

30. McQueen DS, Ritchie IM, Birrell GJ. Arterial chemoreceptor involvement in salicylate-induced hyperventilation in rats. Br J Pharmacol 1989;98:413-24.

31. Haas R, Parker WD Jr, Stumpf D, Eguren LA. Salicylate-induced loose coupling: protonmotive force measurements. Biochem Pharmacol 1985;34:900-2.

32. Kaplan EH, Kennedy J, Davis J. Effects of salicylate and other benzoates on oxidative enzymes of the tricarboxylic acid cycle in rat tissue homogenates. Arch Biochem Biophys 1954;51:47-61.

33. Nulton-Persson AC, Szweda LI, Sadek HA. Inhibition of cardiac mitochondrial respiration by salicylic acid and acetylsalicylate. J Cardiovasc Pharmacol 2004;44: 591-5.

34. Hood VL, Keller U, Haymond MW, Küry D. Systemic pH modifies ketone body production rates and lipolysis in humans. Am J Physiol 1990;259:E327-E334.

35. Stephens TW, Cook GA, Harris RA. Effect of pH on malonyl-CoA inhibition of carnitine palmitoyltransferase I. Biochem J 1983;212:521-4.

36. Smith MJ, Jeffrey SW. The effects of salicylate on oxygen consumption and carbohydrate metabolism in the isolated rat diaphragm. Biochem J 1956;63:524-8.